Medtronic recalls MiniMed 780G insulin pumps (MMT-1884 to MMT-1896) due to potential insulin over- or under-delivery when pump height changes, risking severe hypoglycemia or hyperglycemia.
All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.
Medtronic is recalling MiniMed 780G insulin pumps (model numbers MMT-1884 to MMT-1896) because they can deliver too much or too little insulin if the pump is moved up or down relative to the body. This could cause life-threatening low blood sugar or high blood sugar levels.
The pump can deliver too much insulin (over-delivery) if elevated above the infusion site, causing severe hypoglycemia, seizures, or death. It can also deliver too little insulin (under-delivery) if lowered below the infusion site, causing severe hyperglycemia, dehydration, or death.
People with diabetes who use Medtronic MiniMed 780G insulin pumps (model numbers MMT-1884 to MMT-1896) are affected. Those who have the pump elevated or lowered relative to their infusion site are at higher risk.
Check your pump's model number on the device or in the user guide. The affected models are MMT-1884, MMT-1885, MMT-1886, MMT-1894, MMT-1895, and MMT-1896.
Look for the model number on the pump or in the user guide to confirm if it's affected.
If you have the pump elevated or lowered relative to your infusion site, check your blood sugar more frequently to detect potential issues.
The affected models are MMT-1884, MMT-1885, MMT-1886, MMT-1894, MMT-1895, and MMT-1896.
The pump can deliver too much insulin if elevated above the infusion site, causing severe hypoglycemia, seizures, or death. It can also deliver too little insulin if lowered below the infusion site, causing severe hyperglycemia, dehydration, or death.
No, but you should monitor blood sugar levels closely if you move the pump up or down relative to your infusion site.
We’ve drafted a message you can send Medtronic to request your refund or repair — edit it as you like.
Subject: Recall Z-1741-2026 — Medtronic Medtronic Hello, I own a Medtronic that is covered by recall Z-1741-2026 from Medtronic. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
